| Clue | Drug | % Correct |
|---|---|---|
| peptide hormone produced by beta cells in pancreas | insulin | 81%
|
| antibiotic, discovered by Fleming | penicillin | 62%
|
| Loop diuretic, inhibits NKCC2 in thick ascending limb of loop of Henle | furosemide | 48%
|
| proton-pump inhibitor | omeprazole | 38%
|
| blocks voltage-gated sodium channels, used as local anaesthetic or class I antidysrhythmic | lidocaine | 29%
|
| NSAID, COX inhibitor | aspirin | 27%
|
| potassium-sparing diuretic, aldosterone antagonist | spironolactone | 22%
|
| H2 histamine receptor antagonist | ranitidine | 21%
|
| short-acting beta-2 agonist | salbutamol | 20%
|
| clinically used cardiac glycoside, inhibits sodium/potassium ATPase in myocardium | digoxin | 19%
|
| osmotic diuretic | mannitol | 16%
|
| class III antidysrhythmic agent, prolongs phase 3 of cardiac action potential | amiodarone | 13%
|
| selective beta-1 adrenergic antagonist | atenolol | 13%
|
| L-type calcium channel blocker | verapamil | 13%
|
| endogenous catecholamine, favours beta adrenergic receptors | adrenaline | 12%
|
| non-selective beta adrenergic receptor blocker | propranolol | 12%
|
| diuretic - carbonic anhydrase inhibitor | Acetazolamide | 10%
|
| competitive inverse agonist of muscarinic cholinergic receptors, non-selective | atropine | 8%
|
| prevents vesicular release of ACh, causing paralysis of muscles | botulinum toxin | 8%
|
| potassium-sparing diuretic, blocks eNaC in DCT | amiloride | 7%
|
| CNS stimulant, indirectly acting sympathomimetic (IAS) | amphetamines | 7%
|
| predominantly beta-1 adrenergic agonist | dobutamine | 7%
|
| thiazide diuretic, inhibits sodium reabsorption at beginning of DCT | bendroflumethiazide | 6%
|
| reversible AChE inhibitor, used to improve muscle tone in myasthenia gravis | neostigmine | 6%
|
| binds to voltage-gated sodium channels, blocking passage of sodium ions, found in pufferfish | tetrodotoxin | 6%
|
| non-selective beta agonist | isoprenaline | 4%
|
| depolarising neuromuscular blocker, acting on nicotinic receptors | suxamethonium | 4%
|
| non-depolarising blocking agent, competes for cholinergic receptors at motor end plates. | vecuronium | 3%
|
| Class Ib antidysrhythmic, used in treatment of some forms of long QT syndrome | mexiletine | 1%
|
| cardiac glycoside not clinically used, historically used in poison arrows | ouabain | 1%
|
| nicotinic cholinergic receptor antagonist | tubocurarine | 1%
|